Vital Strategies and the National Council for Behavioral Health have developed a toolkit to help jails and prisons implement and expand access to medications for opioid use disorder, such as methadone and buprenorphine, for incarcerated people struggling with opioid dependence.
To reduce vulnerability to opioid overdose and provide quality care for incarcerated individuals with opioid use disorder, the National Council, in partnership with Vital Strategies and faculty from Johns Hopkins University, developed a new resource guide titled: Medication-Assisted Treatment for Opioid Use Disorder in Jails and Prisons: A Planning and Implementation Toolkitwith funding support from CDC Foundation and Bloomberg Philanthropies.
People who have been incarcerated are up to 100 times more likely than the general public to die from overdose in the weeks following release from incarceration. Despite high rates of opioid dependence among justice-involved individuals, very few jails and prisons offer access to these medications, which can protect against the risk of death.
Expanding access to methadone and buprenorphine across settings, including jails and prisons, is a top priority for Vital Strategies’ overdose prevention work. We look forward to partnering with state and local governments to ensure these life-saving medications get to the people who need them.
Tobacco Control Case Study: Ukraine
The Sobering Truth: Incentivizing Alcohol Death and Disability
Tobacco Control Case Study: Viet Nam
REQUEST FOR PROPOSALS to Reduce Drug-Related Harms Among Communities of Color in Michigan
Lessons From South Africa’s Campaign for a Tax on Sugary Beverages
Tobacco Control Case Study: Turkey
Tobacco Control Case Study: Philippines
Tobacco Control Case Study: Pakistan
Production of a Vital Statistics Report
Acelerando Melhorias da Qualidade do Ar nas Cidades: Guia de Inovação e Ação